TCRX
TScan Therapeutics, Inc.NASDAQHealthcare$1.01+2.97%ClosedMarket Cap: $57.5M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
5
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Thu Jan 22 | Amello Jason | officer: Chief Financial Officer | Sell | 350,000 | $1.12 | 350,000 |
| Thu Jan 22 | MacBeath Gavin | director, officer: Chief Executive Officer | Sell | 1,165,000 | $1.12 | 1,165,000 |
| Thu Jan 22 | Dworak Leiden | officer: See Remarks | Sell | 100,000 | $1.12 | 100,000 |
| Thu Jan 22 | Louis Chrystal | officer: Chief Medical Officer | Sell | 420,000 | $1.12 | 420,000 |
| Thu Jan 22 | ZDRAVESKI ZORAN | officer: See Remarks | Sell | 350,000 | $1.12 | 350,000 |
| Tue Dec 23 | Lynx1 Capital Management LP | 10 percent owner | Buy | 6,232 | $0.90 | 8,019,148 |
| Tue Dec 23 | Lynx1 Capital Management LP | 10 percent owner | Buy | 75,500 | $0.90 | 8,012,916 |
| Tue Dec 23 | Lynx1 Capital Management LP | 10 percent owner | Buy | 80,069 | $0.90 | 7,937,416 |
| Fri Aug 22 | Dworak Leiden | officer: Principal Accounting Officer | Sell | 46,875 | $6.00 | 0 |
| Fri Aug 22 | Dworak Leiden | officer: Principal Accounting Officer | Sell | 25,000 | $2.23 | 0 |